Empyrean Neuroscience is a genetic engineering company developing treatments for neuropsychiatric and neurologic illnesses. Its developmental pipeline comprises fungal alkaloids, cannabinoids, and other neuroactive compounds for the potential treatment of neuropsychiatric and neurologic disorders.